116 related articles for article (PubMed ID: 23143801)
1. Variation in selenoenzyme genes and prostate cancer risk and survival.
Geybels MS; Hutter CM; Kwon EM; Ostrander EA; Fu R; Feng Z; Stanford JL; Peters U
Prostate; 2013 May; 73(7):734-42. PubMed ID: 23143801
[TBL] [Abstract][Full Text] [Related]
2. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.
Peters U; Chatterjee N; Hayes RB; Schoen RE; Wang Y; Chanock SJ; Foster CB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1144-54. PubMed ID: 18483336
[TBL] [Abstract][Full Text] [Related]
3. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
[TBL] [Abstract][Full Text] [Related]
6. Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer.
Geybels MS; van den Brandt PA; Schouten LJ; van Schooten FJ; van Breda SG; Rayman MP; Green FR; Verhage BA
J Natl Cancer Inst; 2014 Mar; 106(3):dju003. PubMed ID: 24563517
[TBL] [Abstract][Full Text] [Related]
7. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
[TBL] [Abstract][Full Text] [Related]
8. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
Penney KL; Schumacher FR; Li H; Kraft P; Morris JS; Kurth T; Mucci LA; Hunter DJ; Kantoff PW; Stampfer MJ; Ma J
Cancer Prev Res (Phila); 2010 May; 3(5):604-10. PubMed ID: 20424130
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans.
Takata Y; King IB; Lampe JW; Burk RF; Hill KE; Santella RM; Kristal AR; Duggan DJ; Vaughan TL; Peters U
J Nutr; 2012 Mar; 142(3):419-26. PubMed ID: 22259188
[TBL] [Abstract][Full Text] [Related]
10. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families.
Karyadi DM; Zhao S; He Q; McIntosh L; Wright JL; Ostrander EA; Feng Z; Stanford JL
Int J Cancer; 2015 May; 136(9):2166-71. PubMed ID: 25273821
[TBL] [Abstract][Full Text] [Related]
12. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.
FitzGerald LM; Zhao S; Leonardson A; Geybels MS; Kolb S; Lin DW; Wright JL; Eeles R; Kote-Jarai Z; Govindasami K; Giles GG; Southey MC; Schleutker J; Tammela TL; Sipeky C; Penney KL; Stampfer MJ; Gronberg H; Wiklund F; Stattin P; Hugosson J; Karyadi DM; Ostrander EA; Feng Z; Stanford JL
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):228-237. PubMed ID: 29298992
[TBL] [Abstract][Full Text] [Related]
13. CYP17 polymorphisms and prostate cancer outcomes.
Wright JL; Kwon EM; Lin DW; Kolb S; Koopmeiners JS; Feng Z; Ostrander EA; Stanford JL
Prostate; 2010 Jul; 70(10):1094-101. PubMed ID: 20503394
[TBL] [Abstract][Full Text] [Related]
14. SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study.
Pellatt AJ; Wolff RK; John EM; Torres-Mejia G; Hines LM; Baumgartner KB; Giuliano AR; Lundgreen A; Slattery ML
PLoS One; 2013; 8(11):e80554. PubMed ID: 24278290
[TBL] [Abstract][Full Text] [Related]
15. Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.
Shui IM; Mucci LA; Wilson KM; Kraft P; Penney KL; Stampfer MJ; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):118-26. PubMed ID: 23125333
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
[TBL] [Abstract][Full Text] [Related]
17. Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer.
Haug U; Poole EM; Xiao L; Curtin K; Duggan D; Hsu L; Makar KW; Peters U; Kulmacz RJ; Potter JD; Koepl L; Caan BJ; Slattery ML; Ulrich CM
Genes Chromosomes Cancer; 2012 Jun; 51(6):598-605. PubMed ID: 22371331
[TBL] [Abstract][Full Text] [Related]
18. Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival.
Oliveira AI; Xavier-Magalhães A; Moreira-Barbosa C; Magalhães H; Henrique R; Jerónimo C; Costa BM
Biomark Med; 2018 Mar; 12(3):257-264. PubMed ID: 29436234
[TBL] [Abstract][Full Text] [Related]
19. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
[TBL] [Abstract][Full Text] [Related]
20. Replication of a genetic variant for prostate cancer-specific mortality.
Penney KL; Shui IM; Feng Z; Sesso HD; Stampfer MJ; Stanford JL
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):260-3. PubMed ID: 25939514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
